The acquisition, announced this morning, adds Bonafide Health to Pharmavite’s existing women’s health portfolio that already includes Equelle and Uqora, which Pharmavite acquired in 2021.
“We’re thrilled to welcome Bonafide Health to Pharmavite. This acquisition positions us as the nation’s leading women’s health nutraceutical company, signaling a new era of innovation and science-based solutions in this underserved space,” Boutelle said following the announcement.
“Bonafide’s unwavering commitment to research, development, and robust scientific evidence mirrors Pharmavite’s rigorous standards, while its deep relationship with healthcare professionals aligns with our goal of ensuring nutrition education is at the forefront of the industry.”
Speaking to NutraIngredients-USA, Boutelle said, “five years ago, we embarked on a transformation to become, among other things, multi-dimensional. That means to continue the intense focus on Nature Made, but also prioritize women’s health as a second platform, if you will.
“So, this acquisition, in addition to our existing women’s health brands Equelle and Uqora, positions us as the strong leader in women’s health in the supplements space now, but also for a very exciting future with the capabilities that Bonafide brings to the party.”
Managing the menopause journey
Bonafide Health is a women’s health company creating a new standard in managing the menopause journey. The company was founded in 2017 with a mission to create scientifically formulated, nature inspired products with clinical evidence and doctor support. Bonafide Health’s six core products – under the names Revaree, Relizen, Ristela, Clairvee, Serenol and The Silvessa System – focus on delivering long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome, sexual satisfaction, and more.
Bonafide will continue to operate out of its current headquarters in Harrison, NY, and there are no workforce implications to the acquisition, according to a press release.
“Our steadfast commitment to science and innovation has allowed us to build something special at Bonafide Health and we’ve been looking for the right partner to grow the business and reach more women that need support. Pharmavite is that partner,” said Michael Satow, co-founder and CEO of Bonafide Health.
“Pharmavite deeply understands the importance of the model we’ve built, from the rigorous scientific data that underpins our products to the power of the work we do with the doctors and other health care providers who are having conversations with women across the country looking for better solutions,” he added.
Pharmavite was advised by Houlihan Lokey. William Hood & Company served as lead financial advisor and EVOLUTION Life Science Partners served as co-advisor to Bonafide Health in the transaction.
Pharmavite’s portfolio
Pharmavite has prioritized the expansion of its women’s health business, which already includes Uqora, a cutting-edge urinary tract health brand, and Equelle, the only supplement with S-equol that is clinically shown to naturally address the root cause of symptoms related to estrogen decline.
Other brands under Pharmavite’s banner are Nature Made, Nature Made Wellblends, Nurish by Nature Made, and MegaFood.
